
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare is a leading healthcare provider operating the largest collection of acute-care hospitals in the United States, with diverse business lines and impressive margins. Despite struggling industry fundamentals, HCA has continued to outperform, driven by strong management, market share gains, and attractive financials. While the company faces potential risks, HCA's scale and competitive positioning, combined with its focus on expanding access to care and corporate social responsibility efforts, make it a strong investment opportunity according to our analysis and continued Outperform rating.
Bears say
HCA Healthcare is facing a decline in Exchange admissions and increasing patient cost sharing. Additionally, the company is experiencing a negative impact from respiratory issues and weather disruptions. In light of these challenges, the financial analyst predicts a lower EBITDA in FY2026 and a downside scenario analysis yields a value of approximately $322. Despite the company's strong presence in fast-growing markets, the unfavorable industry trends and headwinds lead to a negative outlook on HCA Healthcare's stock in the near future.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares